Enhatch has received U.S. Food and Drug Administration (FDA) clearance for its artificial intelligence (AI)-driven instrumentation system to improve total knee arthroplasty, according to a report from Medical Device Network. The novel system—called the Intelligent Surgery Knee software—may streamline preoperative planning and leverage AI-based technology to aid in the development of personalized surgical guides by transforming X-rays or computed tomography (CT) scans into three-dimensional anatomic models. The creators hope that the system may also reduce radiation exposure, provide enhanced precision of anatomic models, and offer a more efficient and cost-effective strategy for preparing patients for total knee arthroplasty. “We are excited to launch this new end-to-end patient-specific system designed to seamlessly integrate into surgical practices,” concluded Scott Mozeleski, BME, Senior Project Research and Development Manager at Enhatch.
February 08, 2024